Abstract:Objective: To investigate the potential of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in mitigating the adverse prognosis associated with central nervous system leukemia (CNSL) and to assess the significance of prophylactic intrathecal injection. Methods: A retrospective cohort analysis was conducted involving 30 patients with acute leukemia who had a history of CNSL who underwent allo-HSCT at Peking University People's Hospital between September 2012 and March 2018 (referred to as the CNSL-positive group). In addition, 90 patients with acute leukemia were selected from the same period who underwent allo-HSCT without a history of CNSL (referred to as the CNSL-negative group) and a rigorous 1∶3 matching was performed based on disease type, disease status, and transplantation type to form the control group. The prognosis between the two groups was compared using Kaplan-Meier analysis and the high-risk factors for CNSL relapse post-transplant were identified through Cox proportional-hazards model. Results: The median age of patients in the CNSL-negative group was significantly higher than that of patients in the CNSL-positive group (32 years vs. 24 years, P=0.014). No significant differences were observed in baseline data, including sex, disease type, disease status at transplantation, donor-recipient relationship, and human leukocyte antigen consistency between the two groups. The median follow-up time was 568 days (range: 21-1 852 days). The 4-year cumulative incidence of relapse (71.4%±20.9% vs. 29.3%±11.5%, P=0.005) and the cumulative incidence of CNSL post-transplant (33.6%±9.2% vs. 1.2%±1.2%, P<0.001) were significantly higher in the CNSL-positive group than in the CNSL-negative group. Furthermore, the 4-year leukemia-free survival rate in the CNSL-positive group was significantly lower than that in the CNSL-negative group (23.1%±17.0% vs. 71.5%±11.6%, P<0.001). However, no significant differences were observed in the 4-year cumulative transplant-related mortality and overall survival rates between the two groups (both P>0.05). Multivariate analysis revealed that a history of CNSL before transplantation (HR=25.050, 95%CI 3.072-204.300, P=0.003) was identified as high-risk factors for CNSL relapse post-transplant. Conversely, haploidentical transplantation was associated with a reduced risk of CNSL relapse post-transplant (HR=0.260, 95%CI 0.073-0.900, P=0.034). Within the CNSL-positive group, seven patients received prophylactic intrathecal therapy after transplantation, and their CNSL relapse rate was significantly lower than that of the 23 patients who did not receive intrathecal therapy after transplantation (0/7 vs. 9/23, P=0.048). Conclusions: Patients with a history of CNSL have a higher risk of relapse and experience poorer leukemia-free survival following transplantation. The use of prophylactic intrathecal injection shows promise in mitigating CNSL relapse rates, although further validation through prospective studies is necessary to substantiate these observations.

Clinical research on acute paraplegia resulting from intrathecal chemotherapy

Multivariate Analysis for Prognostic Factors on Non-Operative Treatment of Cervical Spinal Cord Injury Without Fracture or Dislocation

Paraplegia resulting from intrathecal methotrexate administration in 11 cases:Review of Chinese literature

Clinical Study of Acute Spinal Spontaneous Hematoma

Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia

Risk Factors and Clinical Characteristics of Non-Promyelocytic Acute Myeloid Leukemia of Intracerebral Hemorrhage: A Single Center Study in China.

Clinical and Neuroimaging Characteristics and Prognosis of Patients with Hepatic Myelopathy and Hepatic Encephalopathy

Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation

Analysis of Paraplegia During Transarterial Chemoembolization in Liver Cancer

Myelopathy following intrathecal methotrexate administration:Review of English literature

Efficacy of intrathecal chemotherapy in patients with central nervous system involvement of hematological malignancies: a retrospective analysis

A confounding coincidence: epidural anesthesia and paraplegia due to intramedullary tuberculoma in a patient who underwent cholecystectomy

The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis

[Prognostic Analysis of Patients with Acute Leukemia and Central Nervous System Involvement Undergoing Allogeneic Hematopoietic Stem Cell Transplantation].

Anterior lumbosacral polyradiculopathy after intrathecal administration of methotrexate

Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients

Practical aspects of the use of intrathecal chemotherapy

Primary Study of the Factors Causing Early Death in Patients with Acute Severe Cervical Spinal Cord Injury

Dorsal column myelopathy after intrathecal chemotherapy for leukemia

Anterior lumbosacral polyradiculoneuropathy following intrathecal methotrexate administration: a case report and literature update

Thoraco-lumbar Spinal Fracture Complicated with Subacute Progressive Ascending Paraplegia